Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2008
03/04/2008US7339038 Heparanase specific molecular probes and their use in research and medical applications
03/04/2008US7339037 nucleoside sequence polypeptides; therapy, prevention of influenza viral infections
03/04/2008US7339035 Antibody recognizing GM1 ganglioside-bound amyloid β-protein and DNA encoding the antibody
03/04/2008US7339032 Polypeptides, fragments and homologues; vectors, host cells, antibodies; genetic engineering and expression; treatment of urogenital, sexual, metabolic, inflammatory, pregnancy, and g-protein coupled receptor disorders; drug screening
03/04/2008US7339031 Cancer therapeutics; inhibits protein synthesis on ribosomes
03/04/2008US7339030 Human semaphorin L (H-SemaL) and corresponding semaphorins in other species
03/04/2008US7339029 Sperm-specific cation channel, CatSper2, and uses therefor
03/04/2008US7339028 Mahoganoid polypeptides, and related compositions and methods
03/04/2008US7339026 mda-9 protein
03/04/2008US7338929 Cancer immunotherapy
03/04/2008US7338810 Preparing surfaces comprised of immobilized probes via solid phase synthesis, freezing, drying and pressurization
03/04/2008US7338801 Double transposition methods for manipulating nucleic acids
03/04/2008US7338800 In vivo gene transfer
03/04/2008US7338799 Polynucleotide encoding a mouse choline transporter
03/04/2008US7338797 Compositions for isolating a cDNA encoding a membrane-bound protein
03/04/2008US7338789 Methods of in vitro protein synthesis
03/04/2008US7338788 Cytokines; gene therapy; for treatment of multiple sclerosis and hepatitis
03/04/2008US7338787 Lowering circulating free fatty acid levels in an individual by administering purified, isolated, or recombinant OBG3 or gOBG3 polypeptide fragment that has significantly greater activity than a full-length OBG3 polypeptide; treatment of hyperlipidemias, atherosclerosis, diabetes, and hypertension
03/04/2008US7338786 Nucleic acid and amino acid sequences relating to Streptococcus pneumoniae for diagnostics and therapeutics
03/04/2008US7338781 Organic anion transporting (oat)-like protein UST3-LIKE1 and uses thereof
03/04/2008US7338780 Method for producing tripeptides and/or peptides longer than tripeptides
03/04/2008US7338779 Genetically modifying the Trichoderma production host in such a way that the microorganism does not produce an essential amount of at least one of the proteins, polypeptides or peptides associated with foam formation during cultivation of the unmodified microorganism
03/04/2008US7338776 Production of UGPPase
03/04/2008US7338772 RF-amide peptides and their use for treating, preventing and curing neurological and metabolic medical disorders. The invention also relates to methods for modulating a G-protein coupled receptor and for identifying substances which modulate
03/04/2008US7338771 Use of specific T2R taste receptors to identify compounds that block bitter taste
03/04/2008US7338770 Using calcitonin precursor protein as diagnostic tool in detection of cancer and sepsis
03/04/2008US7338769 Methods for identifying agonists of cypin
03/04/2008US7338764 Polynucleotide microarray including two or more groups of probe polynucleotides immobilized on substrate according to melting temperature and method for detecting target polynucleotides using the same
03/04/2008US7338761 Detection and quantification of human herpes viruses
03/04/2008US7338759 HCV variants
03/04/2008US7338662 Recombinant poxvirus expressing homologous genes inserted into the foxviral genome
03/04/2008US7338660 Methods of treating cancer and enhancing immune responses with antibodies that bind CD40
03/04/2008US7338659 Reducing immunogenicities of immunoglobulins by framework-patching
03/04/2008US7338658 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences
03/04/2008US7338654 Glycosylated interferon alpha obtained from a transgenic chicken
03/04/2008US7338653 Amino-terminally truncated MCP-2 as chemokine antagonists
03/01/2008CA2598060A1 Methods and compositions for the treatment and prevention of cancer
03/01/2008CA2597840A1 Methods and compositions for the treatment and prevention of cancer
02/2008
02/28/2008WO2008025032A1 Soluble il-27 receptor
02/28/2008WO2008024998A2 Expression in insect cells of genes with overlapping open reading frames, methods and compositions therefor
02/28/2008WO2008024983A2 Rnai-mediated inhibition of gremlin for treatment of iop-related conditions
02/28/2008WO2008024518A2 Hcv fusion polypeptides
02/28/2008WO2008024457A2 Rnase a peptides, fragments and uses thereof
02/28/2008WO2008024413A2 Tissue culture system for production of hepatitis c virus
02/28/2008WO2008024409A1 Progenitor cell replication and differentiation in 3d
02/28/2008WO2008024372A2 Pullulanase variants with increased productivity
02/28/2008WO2008024009A1 Transcriptional level of a timp3 gene in the form of a diagnosis marker of a non-small cell carcinoma of lung
02/28/2008WO2008023771A1 Culture vessel, and gene introduction method and cell culture method using the vessel
02/28/2008WO2008023770A1 Baglike container for centrifugation and method of gene introduction using the same
02/28/2008WO2008023717A1 Ophthalmic agent comprising pacap peptide
02/28/2008WO2008023689A1 Method of producing fused protein
02/28/2008WO2008023671A1 Method for highly amplifying target gene in mammalian cell and vector therefor
02/28/2008WO2008023572A1 Chimeric adenovirus, method for producing the same and pharmaceutical using the same
02/28/2008WO2008023469A1 Method of identifying transcriptional factor inducing the production of monascus-origin physiologically active substance and utilization thereof
02/28/2008WO2008023268A2 Leukemia mouse model conditionally expressing a bcr-abl oncogene
02/28/2008WO2008023263A2 Flavin monooxygenases and transcription factors involved in glucosinolate biosynthesis
02/28/2008WO2008023247A2 Matrix attachment regions (mars) for increasing transcription and uses thereof
02/28/2008WO2008022963A2 Isolation and characterization of a novel pythium omega 3 desaturase with specificity to all omega 6 fatty acids longer than 18 carbon chains
02/28/2008WO2008022772A1 Use of light sensitive genes
02/28/2008WO2008022570A1 Method to alleviate abiotic stress in plants
02/28/2008WO2008022486A1 Plant growth and stress tolerance related isozyme, encoding gene and use thereof
02/28/2008WO2008022468A1 Compositions and methods for treating myelosuppression
02/28/2008WO2008022444A1 Small cationic antimicrobial peptides
02/28/2008WO2008022442A1 Composition and method for enhancing plant transformation and homologous recombination
02/28/2008WO2008022391A1 Method for producing antibodies
02/28/2008WO2008003925A3 Complement protein
02/28/2008WO2007148121A3 Nucleic acid molecules encoding an enzyme that degrades long-chain n-alkanes
02/28/2008WO2007145612A8 Paired end sequencing
02/28/2008WO2007144773A3 Recombinant novirhabdoviruses and uses thereof
02/28/2008WO2007141790A3 Plant expression constructs and methods of utilizing same
02/28/2008WO2007140000A3 Administration of the reg1 anticoagulation system
02/28/2008WO2007137973A9 Manipulation of the nitrogen metabolism using ammonium transporter or glucose 6-phosphate deshydrogenases or farnesyl phosphate synthetase (fpp)
02/28/2008WO2007137586A3 Random insertion of peptides
02/28/2008WO2007133674A3 Lentiviral vector compositions, methods and applications
02/28/2008WO2007132269A8 Dub3 as a cancer therapy target
02/28/2008WO2007130518A3 Fermentive production of four carbon alcohols
02/28/2008WO2007127428A3 Double-stranded/self-complementary vectors with a truncated cba promoter and methods of gene delivery
02/28/2008WO2007127221A3 Targeted delivery to leukocytes using non-protein carriers
02/28/2008WO2007126788A3 Methods and compositions for the treatment and prevention of viral infection
02/28/2008WO2007125531A3 Transgenic plants exhibiting increased tolerance to stress and methods of generating same
02/28/2008WO2007120522A3 Permuted and nonpermuted luciferase biosensors
02/28/2008WO2007113837A3 N-terminal vdac variants and uses thereof
02/28/2008WO2007110205A3 Engineered heterodimeric protein domains
02/28/2008WO2007103956A3 Compositions and methods for increasing plant tolerance to high population density
02/28/2008WO2007103290A3 Materials and methods directed to asparagine synthetase and asparaginase therapies
02/28/2008WO2007101273A3 Compositions related to the quantitative trait locus 6 (qtl6) in maize and methods of use
02/28/2008WO2007099459A3 Fad-2 mutants and high oleic plants
02/28/2008WO2007092907A3 Mutation breeding for resistance to disease and other useful traits
02/28/2008WO2007069090A3 Cell penetrating peptides for intracellular delivery of molecules
02/28/2008WO2007064846A3 COMPOSITIONS AND METHODS OF USING siRNA TO KNOCKDOWN GENE EXPRESSION AND TO IMPROVE SOLID ORGAN AND CELL TRANSPLANTATION
02/28/2008WO2007047675A3 Nucleic acids and proteins associated with galactomannan synthesis in coffee
02/28/2008WO2006116682A3 Polypeptides having endoglucanase activity and polynucleotides encoding same
02/28/2008WO2001070932A3 Genetically engineered rabies recombinant vaccine for immunization of stray dogs and wildlife
02/28/2008WO2000040692A3 Methods and compositions for delivering nucleic acids
02/28/2008US20080052795 Arachidonic Acid-Containing Plants and Use of the Plants
02/28/2008US20080052794 Casein Kinase Stress-Related Polypeptides And Methods Of Use In Plants
02/28/2008US20080052793 Seeds
02/28/2008US20080052792 Transgenic plant cell comprising expression vector coding regulatory protein for use in enhancement of drought resistant plants
02/28/2008US20080052791 drought tolerance in plants
02/28/2008US20080052789 Global Gene Expression Analysis of Human Bronchial Epithelial Cells Exposed to Cigarette Smoke, Smoke Condensates, or Components Thereof